文献速递心脑血管急症重症综合管理与镇静镇痛

急性心肌梗死患者住院期间恶性室性心律失常风险临床预测模型的开发与验证

[Development and validation of a clinical predictive model for the risk of malignant ventricular arrhythmia during hospitalization in patients with acute myocardial infarction].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论急性心肌梗死患者住院期间VT/VF发生率为5.06%,VT/VF组院内死亡率38.1% vs 非VT/VF组1.7%(P<0.01);基于Killip≥3级、随机血糖>11.1 mmol/L、LVEF<0.50、频发室早、血钾<3.5 mmol/L、SBP<90 mmHg、Cr>100 μmol/L构建的预测模型AUC为0.779。

该回顾性研究纳入南京医科大学附属常州市第二人民医院心内科2012年12月至2020年8月收治的2 649例急性心肌梗死(AMI)患者,记录性别、年龄、病史、出院诊断、住院期间生命体征、入院心电图、实验室检查、介入治疗、药物使用、恶性室性心律失常(主要为持续性室性心动过速、心室扑动或心室颤动)及死亡情况。按住院期间是否发生VT/VF分组,多因素Logistic回归筛选独立危险因素并构建临床预测模型,绘制ROC曲线计算AUC评价模型准确性。结果显示134例(5.06%)发生VT/VF,VT/VF组院内死亡率显著高于非VT/VF组(38.1% vs. 1.7%,P<0.01);Killip心功能≥3级、随机血糖>11.1 mmol/L、LVEF<0.50、频发室性早搏、血钾<3.5 mmol/L、SBP<90 mmHg、Cr>100 μmol/L为独立危险因素(均P<0.05)。模型预测VT/VF的AUC为0.779(95%CI 0.735-0.823,P<0.001),最佳截断值17,敏感度76.1%,特异度67.3%。

要点

  • AMI患者住院期间VT/VF发生率为5.06%(134/2 649);VT/VF组院内死亡率38.1% vs 非VT/VF组1.7%(P<0.01)。
  • 多因素Logistic回归显示频发室性早搏OR=12.361(95%CI 6.077-25.144)、血钾<3.5 mmol/L OR=4.268(95%CI 2.910-6.259)、Killip≥3级OR=3.540(95%CI 2.336-5.363)为独立危险因素(均P<0.05)。
  • 随机血糖>11.1 mmol/L OR=1.841(95%CI 1.171-2.893)、Cr>100 μmol/L OR=2.498(95%CI 1.170-5.334)亦为独立危险因素(均P<0.05)。
  • LVEF<0.50(OR=0.546,95%CI 0.374-0.797)与SBP<90 mmHg(OR=0.299,95%CI 0.150-0.597)为独立危险因素(均P<0.05)。
  • 预测模型AUC为0.779(95%CI 0.735-0.823,P<0.001),最佳截断值17,敏感度76.1%,特异度67.3%。

适用人群与场景

  • 南京医科大学附属常州市第二人民医院心内科2012年12月至2020年8月收治的2 649例急性心肌梗死(AMI)患者。
  • 按住院期间是否发生VT/VF分为VT/VF组与非VT/VF组。

诊断标准与关键阈值

  • 恶性室性心律失常主要包括持续性室性心动过速(VT)、心室扑动或心室颤动(VF)。
  • 预测模型最佳截断值为17,敏感度76.1%,特异度67.3%。

红旗征与不能漏的情况

  • 住院期间发生VT/VF的AMI患者院内死亡率38.1%,显著高于非VT/VF组的1.7%(P<0.01)。

研究设计与关键结果

  • 回顾性研究,纳入2 649例AMI患者,其中134例(5.06%)住院期间发生VT/VF。
  • VT/VF组与非VT/VF组比较:收缩压125.9±28.2 mmHg vs 132.0±24.2 mmHg,随机血糖8.6±4.8 mmol/L vs 7.4±3.7 mmol/L,Killip心功能≥3级36.6% vs 10.7%,LVEF<0.50 56.7% vs 33.6%,频发室性早搏12.7% vs 1.2%,低钾血症46.3% vs 17.3%,差异均有统计学意义(均P<0.05)。
  • 多因素Logistic回归:Killip≥3级OR=3.540(95%CI 2.336-5.363),随机血糖>11.1 mmol/L OR=1.841(95%CI 1.171-2.893),LVEF<0.50 OR=0.546(95%CI 0.374-0.797),频发室性早搏OR=12.361(95%CI 6.077-25.144),血钾<3.5 mmol/L OR=4.268(95%CI 2.910-6.259),SBP<90 mmHg OR=0.299(95%CI 0.150-0.597),Cr>100 μmol/L OR=2.498(95%CI 1.170-5.334),均为独立危险因素(均P<0.05)。
  • 基于多因素回归筛选变量构建VT/VF风险临床预测模型,ROC曲线分析AUC为0.779(95%CI 0.735-0.823,P<0.001),最佳截断值17,敏感度76.1%,特异度67.3%。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对AMI住院患者,Killip心功能≥3级、随机血糖>11.1 mmol/L、LVEF<0.50、频发室性早搏、血钾<3.5 mmol/L、SBP<90 mmHg、Cr>100 μmol/L为VT/VF独立危险因素,作者认为新建临床预测模型对VT/VF发生风险有一定预测价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To develop and validate a clinical prediction model for the risk of malignant ventricular arrhythmia in patients with acute myocardial infarction (AMI) during hospitalization, and evaluate the effect of the prediction model.

METHODS: A retrospective study was conducted. A total of 2 649 patients with AMI admitted to cardiology department of Changzhou No.2 People's Hospital of Nanjing Medical University from December 2012 to August 2020 were enrolled. The clinical characteristics including gender, age, medical history, discharge diagnosis, vital signs during hospitalization, electrocardiogram characteristics at admission, laboratory examination indexes, interventional treatment, drug usage, malignant ventricular arrhythmias [mainly included sustained ventricular tachycardia (VT), ventricular flutter or ventricular fibrillation (VF)], and death were recorded. All patients were divided into two groups according to whether VT/VF occurred during their hospitalization. Independent risk factors for VT/VF during hospitalization were evaluated by multivariate Logistic regression analysis, and a clinical prediction model was constructed. The receiver operating characteristic curve (ROC curve) was plotted, and the area under ROC curve (AUC) was calculated to evaluate the accuracy of the prediction model.

RESULTS: A total of 2 649 eligible patients with AMI were enrolled, of whom 134 (5.06%) developed VT/VF during hospitalization. The in-hospital mortality rate in VT/VF group was significantly higher than that in non-VT/VF group (38.1% vs. 1.7%, P < 0.01). Compared with the non-VT/VF group, the patients in the VT/VF group with lower systolic blood pressure [SBP (mmHg, 1 mmHg = 0.133 kPa): 125.9±28.2 vs. 132.0±24.2], higher random blood glucose (mmol/L: 8.6±4.8 vs. 7.4±3.7), worse cardiac function [Killip heart function grade ≥ 3: 36.6% vs. 10.7%, left ventricular ejection fraction (LVEF) < 0.50: 56.7% vs. 33.6%, frequent premature ventricular contractions: 12.7% vs. 1.2%] and more hypokalemia (46.3% vs. 17.3%), with significant differences (all P < 0.05). Multivariate Logistic regression analysis showed that Killip classification of cardiac function ≥ 3 [odds ratio (OR) = 3.540, 95% confidence interval (95%CI) was 2.336-5.363], random blood glucose > 11.1 mmol/L (OR = 1.841, 95%CI was 1.171-2.893), LVEF < 0.50 (OR = 0.546, 95%CI was 0.374-0.797), frequent premature ventricular contractions (OR = 12.361, 95%CI was 6.077-25.144), potassium < 3.5 mmol/L (OR = 4.268, 95%CI was 2.910-6.259), SBP < 90 mmHg (OR = 0.299, 95%CI was 0.150-0.597) and creatinine (Cr) > 100 μmol/L (OR = 2.498, 95%CI was 1.170-5.334) were independent risk factors for VT/VF in patients with AMI (all P < 0.05). The clinical prediction model of VT/VF risk was constructed based on the variables selected by multivariate regression analysis. The ROC curve analysis showed that the AUC of the model in predicting VT/VF was 0.779 (95%CI was 0.735-0.823, P < 0.001); the optimal cut-off value of the model was 17, the sensitivity was 76.1%, the specificity was 67.3%.

CONCLUSIONS: The incidence of VT/VF during hospitalization of AMI patients significantly increases the risk of in-hospital death. The independent risk factors of VT/VF are Killip grade ≥ 3, random blood glucose > 11.1 mmol/L, LVEF < 0.50, frequent ventricular premature beats, potassium < 3.5 mmol/L, SBP < 90 mmHg and Cr > 100 μmol/L. The newly constructed clinical prediction model has certain predictive value for the occurrence risk of VT/VF.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Sun L, Mao L, Zou A, et al. [Development and validation of a clinical predictive model for the risk of malignant ventricular arrhythmia during hospitalization in patients with acute myocardial infarction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34053487. doi:10.3760/cma.j.cn121430-20201217-00760

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。